Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 1, 2010
- Accepted for publication July 8, 2010
- Published online October 1, 2010.
Article Versions
- previous version (September 16, 2010 - 08:32).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2010 by Society of Nuclear Medicine
Author Information
- Sandra Heskamp1,
- Hanneke W.M. van Laarhoven1,
- Janneke D.M. Molkenboer-Kuenen2,
- Gerben M. Franssen2,
- Yvonne M.H. Versleijen-Jonkers1,
- Wim J.G. Oyen2,
- Winette T.A. van der Graaf1 and
- Otto C. Boerman2
- 1Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; and
- 2Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- For correspondence or reprints contact: Sandra Heskamp, Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Internal Postal Code 444, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: s.heskamp{at}nucmed.umcn.nl
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models
- PET Imaging of Receptor Tyrosine Kinases in Cancer
- Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
- Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis
- Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody
- Three-Dimensional Histologic Validation of High-Resolution SPECT of Antibody Distributions Within Xenografts
- Advances in Immuno-Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551
- Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
- Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer